Cost minimization analysis of two chemotherapy regimens in the treatment of colorectal cancer in a public reimbursement hospital in Brazil
Objective: To conduct a pharmacoeconomic evaluation between XELOX and mFOLFOX6 in the adjuvant and metastatic treatment of colorectal cancer from the perspective of a public reimbursement hospital. Methods: The cost minimization analysis was conducted for patients who started treatment in 2013 and...
Enregistré dans:
Auteurs principaux: | Sara C. BOSCATO, Márcia R. GODOY, Isabela HEINECK |
---|---|
Format: | article |
Langue: | EN PT |
Publié: |
Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/dcac267a47ea48cb9ed155b9b1f77a35 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Interventions performed by clinical pharmacist in the renal transplant ambulatory care
par: Diego Gnatta, et autres
Publié: (2020) -
Guest editorial: The ten most important qualities for the profession of medicinal research
par: Tony Y. Zhang
Publié: (2021) -
Correction: Structural Racism and Supporting Black Lives – A Pharmacist’s Vow amid COVID-19
par: Nicole D. Avant
Publié: (2021) -
An Overview of COVID-19 Vaccine Safety and Post-marketing Surveillance Systems
par: Manal Mohammed Younus, et autres
Publié: (2021) -
Pharmacy-Based Point-of-Care Testing: How a “Standard of Care” Approach Can Facilitate Sustainability
par: Alex J. Adams, et autres
Publié: (2021)